Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHD

被引:0
|
作者
Biederman, J. [1 ]
Spencer, T. J. [1 ]
Mick, E. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1016/S0924-977X(06)70763-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S545 / S546
页数:2
相关论文
共 50 条
  • [1] Comparative and acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention deficit hyperactivity disorder
    Biederman, J
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 115S - 115S
  • [2] Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
    Joseph Biederman
    Eric O Mick
    Craig Surman
    Robert Doyle
    Paul Hammerness
    Evan Michel
    Jessica Martin
    Thomas J Spencer
    [J]. BMC Psychiatry, 7
  • [3] Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
    Biederman, Joseph
    Mick, Eric O.
    Surman, Craig
    Doyle, Robert
    Hammerness, Paul
    Michel, Evan
    Martin, Jessica
    Spencer, Thomas J.
    [J]. BMC PSYCHIATRY, 2007, 7 (1)
  • [4] Immediate-Release Methylphenidate for the Treatment of ADHD in Adults
    Kocher, Jared
    Adams, Phillip
    [J]. AMERICAN FAMILY PHYSICIAN, 2015, 91 (07) : 445 - 446
  • [5] A Randomized, Single-Blind, Substitution Study of OROS Methylphenidate (Concerta) in ADHD Adults Receiving Immediate Release Methylphenidate
    Spencer, Thomas J.
    Mick, Eric
    Surman, Craig B. H.
    Hammerness, Paul
    Doyle, Robert
    Aleardi, Megan
    Kotarski, Meghan
    Williams, Courtney G.
    Biederman, Joseph
    [J]. JOURNAL OF ATTENTION DISORDERS, 2011, 15 (04) : 286 - 294
  • [6] Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
    Greenhill, Laurence
    Kollins, Scott
    Abikoff, Howard
    McCracken, James
    Riddle, Mark
    Swanson, James
    McGough, James
    Wigal, Sharon
    Wigal, Tim
    Vitiello, Benedetto
    Skrobala, Anne
    Posner, Kelly
    Ghuman, Jaswinder
    Cunningham, Charles
    Davies, Mark
    Chuang, Shirley
    Cooper, Tom
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (11): : 1284 - 1293
  • [7] Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate
    Buitelaar, Jan K.
    Kooij, J. J. Sandra
    Antoni Ramos-Quiroga, J.
    Dejonckheere, Joachim
    Casas, Miguel
    van Oene, Joop C.
    Schauble, Barbara
    Trott, Goetz-Erik
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 554 - 560
  • [8] Treatment of adolescent ADHD with OROS® methylphenidate
    McBurnett, K
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [9] The incidence of personality disorder in adults with ADHD, and the effects on response to treatment with OROS methylphenidate (OROS MPH)
    Casciol, Carissa
    Sassoon, Rachel E.
    Carroll-Sharpe, Abigail
    Essick, Gregory K.
    Baranek, Grace T.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 245S - 245S
  • [10] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637